Drug Type Small molecule drug |
Synonyms BMS 587101 |
Target |
Mechanism ITGAL&ITGB2 antagonists(Integrin alpha-L/beta-2 (LFA-1) antagonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H20Cl2N4O4S |
InChIKeyNXNKJLOEGWSJGI-BKMJKUGQSA-N |
CAS Registry509083-77-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Phase 2 | US | 01 Apr 2005 | |
Inflammation | Phase 2 | US | - | - |